C07F 9/4407
Amides of acyclic saturated acids which can have further substituents on alkyl
Official title: {Amides of acyclic saturated acids which can have further substituents on alkyl}
C07F9/4407 (Amides of acyclic saturated acids which can have further substituents on alkyl) appears on 49 US grants and 28 published applications in this corpus.
Search patents in C07F- Granted patents
- 49
- Published applications
- 28
- Assignees
- 27
- Inventors
- 81
- Latest grant
- 25 Jul 2023
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 5 | 0 |
| 1977 | 0 | 0 |
| 1978 | 0 | 0 |
| 1979 | 1 | 0 |
| 1980 | 2 | 0 |
| 1981 | 0 | 0 |
| 1982 | 2 | 0 |
| 1983 | 1 | 0 |
| 1984 | 1 | 0 |
| 1985 | 4 | 0 |
| 1986 | 0 | 0 |
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 1 | 0 |
| 1990 | 1 | 0 |
| 1991 | 2 | 0 |
| 1992 | 1 | 0 |
| 1993 | 4 | 0 |
| 1994 | 0 | 0 |
| 1995 | 1 | 0 |
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 1 |
| 2002 | 1 | 1 |
| 2003 | 0 | 2 |
| 2004 | 3 | 6 |
| 2005 | 4 | 4 |
| 2006 | 3 | 3 |
| 2007 | 1 | 1 |
| 2008 | 0 | 0 |
| 2009 | 2 | 1 |
| 2010 | 2 | 1 |
| 2011 | 0 | 0 |
| 2012 | 0 | 2 |
| 2013 | 0 | 1 |
| 2014 | 1 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 1 | 0 |
| 2018 | 0 | 1 |
| 2019 | 0 | 0 |
| 2020 | 0 | 1 |
| 2021 | 1 | 1 |
| 2022 | 0 | 0 |
| 2023 | 2 | 2 |
By publication year. Applications have been published since 2001.
Recent patents
- ENPP1 inhibitors and their use for the treatment of cancer25 Jul 2023US 11,707,471 B2The Board of Trustees of the Leland Stanford Junior University
- ENPP1 inhibitors and their use for the treatment of cancer18 Jul 2023US 11,701,371 B2The Board of Trustees of the Leland Stanford Junior University
- Prodrugs of nucleoside phosphonates22 Jun 2021US 11,040,047 B2Katholieke Universiteit Leuven
- Amino terminated phosphonamide oligomers and flame retardant compositions therefrom10 Oct 2017US 9,783,737 B2Frx Polymers, Inc.
- Bisphosphonamidate prodrugs and uses thereof8 Jul 2014US 8,772,268 B2The Johns Hopkins University
- ENPP1 Inhibitors and Their Use for the Treatment of Cancer7 Sep 2023US 2023/0277570 A1The Board of Trustees of the Leland Stanford Junior University
- ENPP1 Inhibitors and Their Use for the Treatment of Cancer6 Apr 2023US 2023/0103498 A1The Board of Trustees of the Leland Stanford Junior University
- ENPP1 Inhibitors and Their Use for the Treatment of Cancer2 Dec 2021US 2021/0369747 A1The Board of Trustees of the Leland Stanford Junior University
- Novel prodrugs of nucleoside phosphonates16 Jan 2020US 2020/0016180 A1Katholieke Universiteit Leuven
- Amino terminated phosphonamide oligomers and flame retardant compositions therefrom10 May 2018US 2018/0127656 A1Frx Polymers, Inc.
Most cited
By later US patents
- Sulfide and disulfide compounds and compositions for cholesterol management and related uses68US 6,703,422 B2Esperion Therapeutics, Inc. · 2004
- Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses65US 6,673,780 B2Esperion Therapeutics, Inc. · 2004
- Ether compounds and compositions for cholesterol management and related uses35US 6,713,507 B2Esperion Therapeutics, Inc. · 2004
- Bis(perfluorosulfonyl)methane salts, and a process for preparing same33US 5,446,134 ACentre National De La Recherche Scientifique · 1995
- Selective elimination of malignant cells from bone marrow by bis (acyloxy) propylphosphoramidates24US 5,055,459 ABoard of Regents, The University of Texas · 1991